Five papers
by Harvey J Clewell
published in 2020
- LG Higgins, LR Chatham, SL Tomczynski, AK MacLeod, M Moreau, HJ Clewell, M Yoon, MR Creek, TG Osimitz, and BG Lake. Differential lymphatic versus portal vein uptake of the synthetic pyrethroids deltamethrin and cis-permethrin in rats. Toxicology 443 : 152563 (Oct 14, 2020). [abstract] [pubmed]
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- P Mallick, G Song, AY Efremenko, SN Pendse, MR Creek, TG Osimitz, RN Hines, P Hinderliter, HJ Clewell, BG Lake, M Yoon, and M Moreau. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids. Toxicol Sci 176 (2) : 460-469 (Aug 1, 2020). [abstract] [pubmed]
- MW Dzierlenga, M Moreau, G Song, P Mallick, PL Ward, JL Campbell, C Housand, M Yoon, BC Allen, HJ Clewell, and MP Longnecker. Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study. Environ Res 182 : 109017 (Mar 9, 2020). [abstract] [pubmed]
- P Mallick, M Moreau, G Song, AY Efremenko, SN Pendse, MR Creek, TG Osimitz, RN Hines, P Hinderliter, HJ Clewell, BG Lake, and M Yoon. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans. Toxicol Sci 173 (1) : 86-99 (Jan 1, 2020). [abstract] [pubmed]